It has been shown that the synthetic peptides (S2-P) corresponding to human SDC2 sequence bound to pro-domain of MMP-7 inhibits SDC2-mediated cancer activities [11], suggesting that S2-P could have potential as an anticancer peptide. This evidence concerns the gene MMP7 and cancer.